Centre of Evidence Based Dermatology
  • Print

CEBD Coronavirus Dermatology Resource

 

Journal articles - Skin manifestations of coronavirus: chilblain-like lesions with acral erythema-oedema-vesicles

 

Dermatology and COVID-19: Much knowledge to date but still a lot to discover.
Le Cleach L.
Ann Dermatol Venereol. 2021 Mar 12:S0151-9638(21)00030-2. doi: 10.1016/j.annder.2021.03.001. Online ahead of print. Review / commentary.
https://doi.org/10.1016/j.annder.2021.03.001

Augmented interferon I signaling in a patient with COVID toes.
Komura K, Ichimura Y, Okiyama N, Watanabe K, Muramoto H, Matsushita T.
J Dermatol. 2021 Mar 21. doi: 10.1111/1346-8138.15864. Online ahead of print. Case report.
https://doi.org/10.1111/1346-8138.15864

Acral changes in pediatric patients during COVID 19 pandemic: Registry report from the COVID 19 response task force of the society of pediatric dermatology (SPD) and pediatric dermatology research alliance (PeDRA).
Castelo-Soccio L, Lara-Corrales I, Paller AS, Bean E, Rangu S, Oboite M, Flohr C, Ahmad RC, Calberg V, Gilliam A, Pope E, Reynolds S, Sibbald C, Shin HT, Berger E, Schaffer J, Siegel MP, Cordoro KM.
Pediatr Dermatol. 2021 Mar 20. doi: 10.1111/pde.14566. Online ahead of print.
https://doi.org/10.1111/pde.14566

"Idiopathic perniosis presenting as acral purpuric lesions: clustering of cases before COVID-19 pandemic and their comparison with chilblain like lesions reported in the literature".
Jindal R, Chauhan P, Goyal D, Shirazi N.
Dermatol Ther. 2021 Mar 19:e14951. doi: 10.1111/dth.14951. Online ahead of print. Case series.
https://doi.org/10.1111/dth.14951

Recurrence of chilblains during a second contact with SARS-CoV-2: a case report.
Maanaoui S, Salez F, Carpentier O.
Br J Dermatol. 2021 Mar 18. doi: 10.1111/bjd.20070. Online ahead of print. Case report.
https://doi.org/10.1111/bjd.20070

Atypical cutaneous and musculoskeletal manifestation of SARS-CoV-2: 'COVID-19 toes' and spasticity in a 48-year-old woman.
Kopacz A, Ludwig C, Tarbox M.
BMJ Case Rep. 2021 Mar 17;14(3):e241410. doi: 10.1136/bcr-2020-241410. Case report.
https://doi.org/10.1136/bcr-2020-241410

Cutaneous manifestations in a series of 417 patients with SARS-CoV-2 infection: epidemiological and clinical correlates of chilblain like lesions.
Brancaccio G, Gussetti N, Sasset L, Alaibac M, Tarantello M, Salmaso R, Trevenzoli M, Cattelan AM.
Pathog Glob Health. 2021 Mar 17:1-4. doi: 10.1080/20477724.2021.1901040. Online ahead of print. Prospective cohort study.
https://doi.org/10.1080/20477724.2021.1901040

Pernio (chilblains), SARS-CoV-2, and COVID toes unified through cutaneous and systemic mechanisms.
Cappel MA, Cappel JA, Wetter DA.
Mayo Clin Proc. 2021 Jan 21:S0025-6196(21)00046-X. doi: 10.1016/j.mayocp.2021.01.009. Online ahead of print. Review.
https://doi.org/10.1016/j.mayocp.2021.01.009

Chilblain-like acral lesions in long COVID-19: management and implications for understanding microangiopathy.
Mehta P, Bunker CB, Ciurtin C, Porter JC, Chambers RC, Papdopoulou C, Garthwaite H, Hillman T, Heightman M, Howell KJ, Eleftheriou D, Denton CP.
Lancet Infect Dis. 2021 Mar 8:S1473-3099(21)00133-X. doi: 10.1016/S1473-3099(21)00133-X. Online ahead of print. Commentary.
https://doi.org/10.1016/s1473-3099(21)00133-x

Cold and COVID: Recurrent pernio during the COVID-19 pandemic.
Freeman EE, McMahon DE, Lipoff JB, Rosenbach M, Desai SR, Fassett M, French LE, Lim HW, Hruza GJ, Fox LP.
Br J Dermatol. 2021 Mar 3. doi: 10.1111/bjd.19894. Online ahead of print. Patient registry study.
https://doi.org/10.1111/bjd.19894

Association between COVID-19 and chilblains: A case-control study.
Ortega-Quijano D, Fernandez-Nieto D, Jimenez-Cauhe J, Cortes-Cuevas JL, Marcos-Mencia D, Rodriguez-Dominguez M, Segurado-Miravalles G, Fernandez-Guarino M, Jaen-Olasolo P.
J Eur Acad Dermatol Venereol. 2021 Mar 2. doi: 10.1111/jdv.17195. Online ahead of print. Case-control study.
https://doi.org/10.1111/jdv.17195

Chilblains in a child with confirmed SARS-CoV-2 infection: a red flag for late onset skin manifestation in previously infected individuals.
Neri I, Conti F, Virdi A, Guglielmo A, Leonardi L, Corsini I, Ghizzi C, Gabrielli L, Lazzarotto T, Lanari M, Patrizi A, Misciali C.
J Eur Acad Dermatol Venereol. 2021 Mar 2. doi: 10.1111/jdv.17194. Online ahead of print. Case report.
https://doi.org/10.1111/jdv.17194

Polymorphous acral eruption and Covid-19.
Elkhachine Y, Sakkah A, Hallab I, Jakar A, Elhaouri M, Elbenaye J.
Pan Afr Med J. 2020 May 26;35(Suppl 2):49. doi: 10.11604/pamj.supp.2020.35.2.23576. eCollection 2020. Case reports.
https://doi.org/10.11604/pamj.supp.2020.35.2.23576

Reader Comment Regarding "Approach to Chilblains During the COVID-19 Pandemic".
López-Sundh AE, Gómez-Fernández C, González-López MA.
J Cutan Med Surg. 2021 Feb 24:1203475421997355. doi: 10.1177/1203475421997355. Online ahead of print. Commentary.
https://doi.org/10.1177/1203475421997355

Response to Reader Comment Regarding "Approach to Chilblains During the COVID-19 Pandemic".
Ladha MA, Luca N, Constantinescu C, Naert K, Ramien ML.
J Cutan Med Surg. 2021 Feb 24:1203475421997405. doi: 10.1177/1203475421997405. Online ahead of print. Commentary.
https://doi.org/10.1177/1203475421997405

'Blue toes' following vaccination with the BNT162b2 mRNA COVID-19 vaccine.
Davido B, Mascitti H, Fortier-Beaulieu M, Jaffal K, de Truchis P.
J Travel Med. 2021 Feb 23:taab024. doi: 10.1093/jtm/taab024. Online ahead of print. Case report.
https://doi.org/10.1093/jtm/taab024

Relapse of chilblain-like lesions during the second wave of COVID-19.
Recalcati S, Barbagallo T, Tonolo S, Milani M, Fantini F.
J Eur Acad Dermatol Venereol. 2021 Feb 15. doi: 10.1111/jdv.17168. Online ahead of print. Case series & commentary.
https://doi.org/10.1111/jdv.17168

Pseudo-chilblain lesions and COVID-19: a controversial relationship.
Vázquez-Osorio I, Rocamonde L, Treviño-Castellano M, Vázquez-Veiga H, Ginarte M.
Int J Dermatol. 2021 Feb 9. doi: 10.1111/ijd.15422. Online ahead of print. Case series & pathology study.
https://doi.org/10.1111/ijd.15422

Acute acral eruptions in children during the COVID-19 pandemic: Characteristics of 103 children and their family clusters.
Hubiche T, Phan A, Leducq S, Rapp J, Fertitta L, Aubert H, Barbarot S, Chiaverini C, Giraudeau B, Lasek A, Mallet S, Labarelle A, Piram M, McCuaig C, Martin L, Monitor L, Nicol I, Bissuel M, Bellissen A, Jullien D, Lesort C, Vabres P, Maruani A; Research Group of the Société Française de Dermatologie Pédiatrique (French Society of Pediatric Dermatology).
Ann Dermatol Venereol. 2021 Jan 9:S0151-9638(21)00005-3. doi: 10.1016/j.annder.2020.11.005. Online ahead of print. Cross-sectional study.
https://doi.org/10.1016/j.annder.2020.11.005

Chilblain-like lesions and COVID-19: second wave, second outbreak.
Piccolo V, Bassi A, Russo T, Mazzatenta C, Baraldi M, Argenziano G, Neri I, Cutrone M.
J Eur Acad Dermatol Venereol. 2021 Feb 5. doi: 10.1111/jdv.17145. Online ahead of print. Case series.
https://doi.org/10.1111/jdv.17145

Chilblains and COVID-19: Can recent epidemiological data shed light on the etiological debate?
Baeck M, Herman A.
Clin Exp Dermatol. 2021 Jan 31. doi: 10.1111/ced.14586. Online ahead of print. Commentary and case series.
https://doi.org/10.1111/ced.14586

The influence of mediatization and governmental policies on Google queries related to COVID-19 cutaneous symptoms: Infodemiology study.
Huynh S, Duong TA, Lame G, Hubiche T, Ezzedine K.
JMIR Public Health Surveill. 2021 Jan 22. doi: 10.2196/25651. Online ahead of print. Google search data analysis.
https://doi.org/10.2196/25651

Histopathologic features of chilblainlike lesions developing in the setting of the coronavirus disease 2019 (COVID-19) pandemic.
Sohier P, Matar S, Meritet JF, Laurent-Roussel S, Dupin N, Aractingi S.
Arch Pathol Lab Med. 2021 Feb 1;145(2):137-144. doi: 10.5858/arpa.2020-0613-SA. Case series & pathology study.
https://doi.org/10.5858/arpa.2020-0613-sa

The clinical spectrum of COVID-19-associated cutaneous manifestations: an Italian multicentre study of 200 adult patients.
Marzano AV, Genovese G, Moltrasio C, Gaspari V, Vezzoli P, Maione V, Misciali C, Sena P, Patrizi A, Offidani A, Quaglino P, Arco R, Caproni M, Rovesti M, Bordin G, Recalcati S, Potenza C, Guarneri C, Fabbrocini G, Tomasini C, Sorci M, Lombardo M, Gisondi P, Conti A, Casazza G, Peris K, Calzavara-Pinton P, Berti E; Italian SkinCovid-19 Network of the Italian Society of Dermatology and Sexually Transmitted Diseases (SIDeMaST).
J Am Acad Dermatol. 2021 Jan 18:S0190-9622(21)00166-3. doi: 10.1016/j.jaad.2021.01.023. Online ahead of print. Cross-sectional study.
https://doi.org/10.1016/j.jaad.2021.01.023

Long COVID in the skin: a registry analysis of COVID-19 dermatological duration.
McMahon DE, Gallman AE, Hruza GJ, Rosenbach M, Lipoff JB, Desai SR, French LE, Lim H, Cyster JG, Fox LP, Fassett MS, Freeman EE.
Lancet Infect Dis. 2021 Jan 15:S1473-3099(20)30986-5. doi: 10.1016/S1473-3099(20)30986-5. Online ahead of print. Registry / cohort study.
https://doi.org/10.1016/s1473-3099(20)30986-5

Chilblain-like lesions during COVID-19 pandemic: The state of the art.
Bassi A, Russo T, Argenziano G, Mazzatenta C, Venturini E, Neri I, Piccolo V.
Life (Basel). 2021 Jan 2;11(1):E23. doi: 10.3390/life11010023. Review.
https://doi.org/10.3390/life11010023

Emerging evidence of the direct association between COVID-19 and chilblains.
Freeman EE, McMahon DE, Fox LP.
JAMA Dermatol. 2020 Dec 23. doi: 10.1001/jamadermatol.2020.4937. Online ahead of print. Commentary.
https://doi.org/10.1001/jamadermatol.2020.4937

Emerging evidence of the direct association between COVID-19 and chilblains - Reply.
Baeck M, Herman A.
JAMA Dermatol. 2020 Dec 23. doi: 10.1001/jamadermatol.2020.4655. Online ahead of print. Commentary.
https://doi.org/10.1001/jamadermatol.2020.4655

COVID toes or pernio?
Zaladonis A, Huang S, Hsu S.
Clin Dermatol. 2020 Nov-Dec;38(6):764-767. doi: 10.1016/j.clindermatol.2020.06.002. Epub 2020 Jun 5. Review / commentary.
https://doi.org/10.1016/j.clindermatol.2020.06.002

SARS-CoV-2 has not been detected directly by electron microscopy in the endothelium of chilblain lesions: reply from the authors.
Colmenero I, Santonja C, Alonso-Riaño M, Andina D, Rodríguez Peralto JL, Requena L, Torrelo A.
Br J Dermatol. 2020 Dec 16. doi: 10.1111/bjd.19595. Online ahead of print. Commentary.
https://doi.org/10.1111/bjd.19595

Chilblain-like eruption in COVID-19 disease: possible pathogenetic role of temperature.
Wee C, Tey HL.
Eur J Dermatol. 2020 Dec 11. doi: 10.1684/ejd.2020.3943. Online ahead of print. Commentary.
https://doi.org/10.1684/ejd.2020.3943

Type I interferon signature in chilblain-like lesions associated with the COVID-19 pandemic.
Aschoff R, Zimmermann N, Beissert S, Günther C.
Dermatopathology (Basel). 2020 Dec 4;7(3):57-63. doi: 10.3390/dermatopathology7030010. Case reports.
https://doi.org/10.3390/dermatopathology7030010

Rheumatic manifestations of COVID-19: a systematic review and meta-analysis.
Ciaffi J, Meliconi R, Ruscitti P, Berardicurti O, Giacomelli R, Ursini F.
BMC Rheumatol. 2020 Oct 28;4(1):65. doi: 10.1186/s41927-020-00165-0. Systematic review.
https://doi.org/10.1186/s41927-020-00165-0

Petechial lesions in a patient with COVID-19.
Fujimoto LBM, Ferreira SAD, Santos FBD, Talhari C.
An Bras Dermatol. 2020 Nov 26:S0365-0596(20)30353-6. doi: 10.1016/j.abd.2020.08.007. Online ahead of print. Case report.
https://doi.org/10.1016/j.abd.2020.08.007

Delayed hypersensitivity as a pathophysiological mechanism in cutaneous lesions due to SARS-CoV-2.
Rafai M, Elbenaye J, Sabry S, Janah H.
Pan Afr Med J. 2020 Jul 16;35(Suppl 2):115. doi: 10.11604/pamj.supp.2020.35.2.24980. eCollection 2020. Case report.
https://doi.org/10.11604/pamj.supp.2020.35.2.24980

Skin manifestations during the COVID-19 pandemic in the pediatric emergency department.
Oliva Rodríguez-Pastor S, Martín Pedraz L, Carazo Gallego B, Galindo Zavala R, Lozano Sánchez G, de Toro Pseinado I, Rodriguez Benjumea M, Mejias A, Cuadros EN.
Pediatr Int. 2020 Dec 5. doi: 10.1111/ped.14568. Online ahead of print. Prospective cohort study.
https://doi.org/10.1111/ped.14568

Incidence, characteristics, laboratory findings and outcomes in acro-ischemia in COVID-19 patients.
Alonso MN, Mata-Forte T, García-León N, Vullo PA, Ramirez-Olivencia G, Estébanez M, Álvarez-Marcos F.
Vasc Health Risk Manag. 2020 Nov 24;16:467-478. doi: 10.2147/VHRM.S276530. eCollection 2020. Prospective cohort & pathology study.
https://doi.org/10.2147/vhrm.s276530

Impaired type I interferon response in SARS-CoV-2 infection: looking through the cutaneous window.
Bessis D.
Br J Dermatol. 2020 Nov 29. doi: 10.1111/bjd.19596. Online ahead of print. Commentary.
https://doi.org/10.1111/bjd.19596

Clinical, laboratory, and interferon-alpha response characteristics of patients with chilblain-like lesions during the COVID-19 pandemic.
Hubiche T, Cardot-Leccia N, Le Duff F, Seitz-Polski B, Giordana P, Chiaverini C, Giordanengo V, Gonfrier G, Raimondi V, Bausset O, Adjtoutah Z, Garnier M, Burel-Vandenbos F, Dadone-Montaudié B, Fassbender V, Palladini A, Courjon J, Mondain V, Contenti J, Dellamonica J, Leftheriotis G, Passeron T.
JAMA Dermatol. 2020 Nov 25. doi: 10.1001/jamadermatol.2020.4324. Online ahead of print. Prospective cohort / pathology study.
https://doi.org/10.1001/jamadermatol.2020.4324

What are COVID toes? A case study.
Beuscher TL, Andrews SE.
J Wound Ostomy Continence Nurs. 2020 Nov/Dec;47(6):619-621. doi: 10.1097/WON.0000000000000711. Case report & commentary.
https://doi.org/10.1097/won.0000000000000711

Skin manifestations of COVID-19 in children: Part 1.
Andina D, Belloni-Fortina A, Bodemer C, Bonifazi E, Chiriac A, Colmenero I, Diociaiuti A, El-Hachem M, Fertita L, van Gysel D, Hernández-Martín A, Hubiche T, Luca C, Martos-Cabrera L, Maruani A, Mazzotta F, Akkaya AD, Casals M, Ferrando J, Grimalt R, Grozdev I, Kinsler V, Morren MA, Munisami M, Nanda A, Novoa MP, Ott H, Pasmans S, Salavastru C, Zawar V, Torrelo A; ESPD Group for the Skin Manifestations of COVID-19.
Clin Exp Dermatol. 2020 Nov 12. doi: 10.1111/ced.14481. Online ahead of print. Review.
https://doi.org/10.1111/ced.14481

COVID purpura (toes) case series: A chilblains-like vasculopathy.
Wargo JJ, Shrit MA, Feeser TA, Olsen TG.
Am J Dermatopathol. 2020 Nov 3. doi: 10.1097/DAD.0000000000001829. Online ahead of print. Case series.
https://doi.org/10.1097/dad.0000000000001829

Chilblains-like lesions and SARS-CoV-2 in children: an overview in therapeutic approach.
Pavone P, Marino S, Marino L, Cacciaguerra G, Guarneri C, Nunnari G, Taibi R, Marletta L, Falsaperla R.
Dermatol Ther. 2020 Nov 3:e14502. doi: 10.1111/dth.14502. Online ahead of print. Case reports.
https://doi.org/10.1111/dth.14502

Chilblain-like lesions with prominent bullae in a patient with COVID-19.
Rubin A, Alamgir M, Rubin J, Rao BK.
BMJ Case Rep. 2020 Nov 2;13(11):e237917. doi: 10.1136/bcr-2020-237917. Case report.
https://doi.org/10.1136/bcr-2020-237917

Suspected COVID-19-related reticulated purpura of the soles in an infant.
Andina D, Colmenero I, Santonja C, Muñoz de León I, Noguera-Morel L, Hernández-Martín A, Torrelo A.
Pediatr Dermatol. 2020 Oct 21. doi: 10.1111/pde.14409. Online ahead of print. Case report.
https://doi.org/10.1111/pde.14409

COVID toes: where do we stand with the current evidence?
Baeck M, Herman A.
Int J Infect Dis. 2020 Oct 16:S1201-9712(20)32225-6. doi: 10.1016/j.ijid.2020.10.021. Online ahead of print. Review / commentary.
https://doi.org/10.1016/j.ijid.2020.10.021

Treatment of COVID-19 induced chilblains with topical nitroglycerin.
Weingarten M, Abittan B, Rivera-Oyola R, Abittan AI, Weingarten M, Lebwohl M.
Int J Dermatol. 2020 Oct 20. doi: 10.1111/ijd.15253. Online ahead of print. Case report.
https://doi.org/10.1111/ijd.15253

Two cases of skin manifestations prior to the onset of COVID-19 respiratory symptoms.
Altayeb A, Cordaro A, Caesar J, Vyas J, Ingram J.
Int J Dermatol. 2020 Oct 20. doi: 10.1111/ijd.15247. Online ahead of print. Case reports.
https://doi.org/10.1111/ijd.15247

High prevalence of cryofibrinogenemia in patients with chilblains during the COVID-19 outbreak.
Gómez-Fernández C, López-Sundh AE, González-Vela C, Ocejo-Vinyals JG, Mayor-Ibarguren A, Salas-Venero CA, Gutiérrez-Larrañaga M, Tejerina-Puente A, Fariñas MC, Cabero-Pérez MJ, López-Hoyos M, González-López MA.
Int J Dermatol. 2020 Oct 17. doi: 10.1111/ijd.15234. Online ahead of print. Prospective cohort study.
https://doi.org/10.1111/ijd.15234

Erythema pernio-like in four adolescents in the era of the coronavirus-2 infection.
Promenzio L, Arcangeli F, Cortis E, Sama E, Longhini F.
Rev Recent Clin Trials. 2020 Oct 16. doi: 10.2174/1574887115666201016153031. Online ahead of print. Case reports.
https://doi.org/10.2174/1574887115666201016153031

Histopathological features of chilblain-like lesions developing in the setting of the COVID-19 pandemic.
Sohier P, Matar S, Meritet JF, Laurent-Roussel S, Dupin N, Aractingi S.
Arch Pathol Lab Med. 2020 Oct 9. doi: 10.5858/arpa.2020-0613-SA. Online ahead of print. Case series / pathology study.
https://doi.org/10.5858/arpa.2020-0613-sa

Chilblain-like lesions and COVID-19 infection: A prospective observational study at Spain´s ground zero.
Feito-Rodríguez M, Mayor-Ibarguren A, Hijón C, Montero-Vega D, Servera-Negre G, Ruiz-Bravo E, Nozal P, Rodríguez-Peralto JL, Enguita AB, Bravo-Gallego LY, Granados-Fernández M, Fernández-Alcalde C, Fernández-Heredero A, Alonso-Riaño M, Jiménez-Yuste V, Nuño-González A, De Lucas-Laguna R, López-Granados E, Herranz-Pinto P.
J Am Acad Dermatol. 2020 Oct 3:S0190-9622(20)32687-6. doi: 10.1016/j.jaad.2020.09.086. Online ahead of print. Prospective cohort study.
https://doi.org/10.1016/j.jaad.2020.09.086

A new dermoscopic pattern for chilblain-COVID-like skin lesion in the adolescent.
Fabbrocini G, Vastarella M, Nappa P, Annunziata MC, Camela E, Greco V, Gaudiello F, Alessio M, Pierri L, Catzola A, Guarino A.
JAAD Case Rep. 2020 Oct 1. doi: 10.1016/j.jdcr.2020.09.024. Online ahead of print. Case report.
https://doi.org/10.1016/j.jdcr.2020.09.024

Dermoscopy of chilblain-like lesions during the COVID-19 outbreak: A multicenter study on 10 patients.
Piccolo V, Bassi A, Argenziano G, Mazzatenta C, Guglielmo A, Patrizi A, Neri I.
J Am Acad Dermatol. 2020 Sep 30:S0190-9622(20)32257-X. doi: 10.1016/j.jaad.2020.07.058. Online ahead of print. Case series.
https://doi.org/10.1016/j.jaad.2020.07.058

Immunological and virological profile of children with chilblain-like lesions and SARS-CoV-2.
Fertitta L, Welfringer A, Ouedrani A, Polivka L, Chhun S, Chatenoud L, Fourgeaud J, Hadj-Rabia S, Temmam S, Eloit M, Sermet-Gaudelus, Bodemer C.
J Eur Acad Dermatol Venereol. 2020 Oct 3. doi: 10.1111/jdv.16972. Online ahead of print. Case series & pathology study.
https://doi.org/10.1111/jdv.16972

Why are chilblains underreported in Nordic countries during the COVID-19 pandemic? An analysis of Google trends.
Kluger N.
J Eur Acad Dermatol Venereol. 2020 Oct 3. doi: 10.1111/jdv.16974. Online ahead of print. Internet search analysis.
https://doi.org/10.1111/jdv.16974

SARS-CoV-2 has not been detected directly by electron microscopy in the endothelium of chilblain lesions: reply from authors.
Colmenero I, Santonja C, Alonso-Riaño M, Andina D, Rodríguez Peralto JL, Requena L, Torrelo A.
Br J Dermatol. 2020 Sep 30. doi: 10.1111/bjd.19579. Online ahead of print. Commentary.
https://doi.org/10.1111/bjd.19579

SARS-CoV-2 has not been detected directly by electron microscopy in the endothelium of chilblain lesions.
Brealey JK, Miller SE.
Br J Dermatol. 2020 Sep 30. doi: 10.1111/bjd.19572. Online ahead of print. Commentary.
https://doi.org/10.1111/bjd.19572

SARS-CoV-2 spike protein is present in both endothelial and eccrine cells of a chilblain-like skin lesion.
Gambichler T, Reuther J, Stücker M, Stranzenbach R, Torres-Reyes C, Schlottmann R, Schmidt WE, Hayajneh R, Sriram A, Becker JC.
J Eur Acad Dermatol Venereol. 2020 Oct 1. doi: 10.1111/jdv.16970. Online ahead of print. Case report / pathology study.
https://doi.org/10.1111/jdv.16970

COVID-19 elbows: first report in Saudi Arabia.
Al-Dawsari NA, Abulhamayel Y.
Int J Dermatol. 2020 Sep 29. doi: 10.1111/ijd.15182. Online ahead of print. Case report.
https://doi.org/10.1111/ijd.15182

Response to 'No evidence of SARS-CoV-2 infection by polymerase chain reaction or serology in children with pseudo-chilblain'. Reply from the authors.
Caselli D, Chironna M, Loconsole D, Aricò M.
Br J Dermatol. 2020 Sep 25. doi: 10.1111/bjd.19563. Online ahead of print. Commentary.
https://doi.org/10.1111/bjd.19563

No SARS-CoV-2 antibody response in 25 patients with pseudo-chilblains.
Docampo-Simón A, Sánchez-Pujol MJ, Gimeno-Gascon A, Palazón-Cabanes JC, Juan-Carpena G, Vergara-De Caso E, González-Villanueva I, Blanes-Martínez M, Betlloch-Mas I.
Dermatol Ther. 2020 Sep 25. doi: 10.1111/dth.14332. Online ahead of print. Case series & pathology study.
https://doi.org/10.1111/dth.14332

Pernio-like lesions and coagulopathy in a patient with COVID-19 infection.
Micevic G, Morris J, Lee AI, King BA.
JAAD Case Rep. 2020 Sep 15. doi: 10.1016/j.jdcr.2020.08.042. Online ahead of print. Case report.
https://doi.org/10.1016/j.jdcr.2020.08.042

Management of pernio-like cutaneous manifestations in children during the outbreak of covid-19.
Gallizzi R, Sutera D, Spagnolo A, Bagnato AM, Cannavò SP, Grasso L, Guarneri C, Nunnari G, Mazza F, Pajno GB.
Dermatol Ther. 2020 Sep 19:e14312. doi: 10.1111/dth.14312. Online ahead of print. Case series.
https://doi.org/10.1111/dth.14312

COVID toes and other cutaneous manifestations of COVID-19.
Rose-Sauld S, Dua A.
J Wound Care. 2020 Sep 2;29(9):486-487. doi: 10.12968/jowc.2020.29.9.486. Review.
https://doi.org/10.12968/jowc.2020.29.9.486

Are SARS-CoV-2 IgA antibodies in pediatric patients with chilblain-like lesions indicative of COVID-19 asymptomatic or paucisymptomatic infection?
Diociaiuti A, Giancristoforo S, Terreri S, Corbeddu M, Concato C, Ciofi Degli Atti M, Zambruno G, Carsetti R, El Hachem M.
J Eur Acad Dermatol Venereol. 2020 Sep 13. doi: 10.1111/jdv.16934. Online ahead of print. Case series / pathology study.
https://doi.org/10.1111/jdv.16934

Reply to pernio during the COVID-19 pandemic and review of inflammation patterns and mechanisms of hypercoagulability.
Kolivras A, Thompson CT, Richert B.
JAAD Case Rep. 2020 Jun 6;6(9):954-955. doi: 10.1016/j.jdcr.2020.06.003. eCollection 2020 Sep. Commentary.
https://doi.org/10.1016/j.jdcr.2020.06.003

Case report: Chilblains-like lesions (COVID-19 toes) during the pandemic - is there a diagnostic window?
Ludzik J, Witkowski A, Hansel DE, Raess PW, White K, Leachman S.
F1000Res. 2020 Jul 2;9:668. doi: 10.12688/f1000research.24766.2. eCollection 2020. Case report.
https://doi.org/10.12688/f1000research.24766.2

[Acro-ischemic injuries in children-adolescents during CoViD-19 pandemic: from lifestyle changes due to lockdown to interferone.].
Marchetti F, Guiducci C, Bigucci B, Iacono A, Calderoni O, Sorci MR, Sparacino M, Semprini S, Vergine G.
Recenti Prog Med. 2020 Sep;111(9):480-486. doi: 10.1701/3421.34060. Italian. Commentary.
https://doi.org/10.1701/3421.34060

Acral lesions in a pediatric population during the COVID-19 pandemic: a case series of 36 patients from a single hospital in Spain.
Rosés-Gibert P, Gimeno Castillo J, Saenz Aguirre A, De la Torre Gomar FJ, Carnero González L, Martinez de Lagrán Alvarez de Arcaya Z, Gonzalez-Perez R.
World J Pediatr. 2020 Sep 8. doi: 10.1007/s12519-020-00390-0. Online ahead of print. Case series.
https://doi.org/10.1007/s12519-020-00390-0

Discordant anti-SARS-CoV-2 spike protein and RNA staining in cutaneous perniotic lesions suggests endothelial deposition of cleaved spike protein.
Ko CJ, Harigopal M, Gehlhausen JR, Bosenberg M, McNiff JM, Damsky W.
J Cutan Pathol. 2020 Sep 7. doi: 10.1111/cup.13866. Online ahead of print. Case series / pathology study.
https://doi.org/10.1111/cup.13866

Immunoglobulin A antiphospholipid antibodies in patients with chilblain-like lesions during the COVID-19 pandemic.
Cuenca Saez MA, Gomez-Biezna SL.
Actas Dermosifiliogr. 2020 Sep 6:S0001-7310(20)30311-2. doi: 10.1016/j.ad.2020.08.006. Online ahead of print. English, Spanish. Case series.
https://doi.org/10.1016/j.ad.2020.08.006

Response to "No evidence of SARS-CoV-2 infection by PCR or serology in children with pseudochilblain".
Recalcati S, Tonolo S, Luzzaro F, Fantini F.
Br J Dermatol. 2020 Aug 16. doi: 10.1111/bjd.19493. Online ahead of print. Commentary.
https://doi.org/10.1111/bjd.19493 

Pernio during the COVID-19 pandemic and review of inflammation patterns and mechanisms of hypercoagulability.
Cavanagh G, Criado PR, Pagliari C, Oliveira Carneiro FR, Simões Quaresma JA, Cappel MA, Wambier C.
JAAD Case Rep. 2020 Jun 6;6(9):898-899. doi: 10.1016/j.jdcr.2020.06.002. eCollection 2020 Sep. Commentary.
https://doi.org/10.1016/j.jdcr.2020.06.002

Illuminating, through immunohistochemistry, the link between SARS-CoV-2 and pernio (chilblains).
Wetter DA.
Br J Dermatol. 2020 Sep 1. doi: 10.1111/bjd.19405. Online ahead of print. Commentary.
https://doi.org/10.1111/bjd.19405

Chilblains and COVID-19: further evidence against a causal association.
Baeck M, Peeters C, Herman A.
J Eur Acad Dermatol Venereol. 2020 Aug 31. doi: 10.1111/jdv.16901. Online ahead of print. Pathology study & commentary.
https://doi.org/10.1111/jdv.16901

Do we have serological evidences that chilblain-like lesions are related to SARS-CoV-2? A review of the literature.
Balestri R, Magnano M, Rizzoli L, Rech G.
Dermatol Ther. 2020 Aug 26:e14229. doi: 10.1111/dth.14229. Online ahead of print. Review.
https://doi.org/10.1111/dth.14229

Pernio-like eruption associated with COVID-19 in skin of color.
Daneshjou R, Rana J, Dickman M, Yost JM, Chiou A, Ko J.
JAAD Case Rep. 2020 Sep;6(9):892-897. doi: 10.1016/j.jdcr.2020.07.009. Epub 2020 Jul 12. Case series.
https://doi.org/10.1016/j.jdcr.2020.07.009

Evaluation of SARS-CoV-2 antibodies in 24 patients presenting with chilblains-like lesions during the COVID-19 pandemic.
Stavert R, Meydani-Korb A, de Leon D, Osgood R, Blau J, Luu T.
J Am Acad Dermatol. 2020 Aug 18:S0190-9622(20)32440-3. doi: 10.1016/j.jaad.2020.08.049. Online ahead of print. Case series / pathology study.
https://doi.org/10.1016/j.jaad.2020.08.049

Chilblains in COVID-19 Infection.
Mohan V, Lind R.
Cureus. 2020 Jul 17;12(7):e9245. doi: 10.7759/cureus.9245. Case report & review.
https://doi.org/10.7759/cureus.9245

A case of COVID-19 with late-onset rash and transient loss of taste and smell in a 15-year-old boy.
Maniaci A, Iannella G, Vicini C, Pavone P, Nunnari G, Falsaperla R, Di Mauro P, Ferlito S, Cocuzza S.
Am J Case Rep. 2020 Aug 20;21:e925813. doi: 10.12659/AJCR.925813. Case report.
https://doi.org/10.12659/ajcr.925813

[Comment on «Chilblains in lockdown: An old acquaintance in the context of COVID 19»].
Torres-Navarro I, Sánchez-Arráez J, Roca-Ginés J, Abril-Pérez C.
An Pediatr (Barc). 2020 Jul 30:S1695-4033(20)30262-9. doi: 10.1016/j.anpedi.2020.07.011. Online ahead of print. Spanish. Commentary.
https://doi.org/10.1016/j.anpedi.2020.07.011

Similarities in cutaneous histopathological patterns between COVID-19-positive and COVID-19 high-risk patients with skin dermatosis.
Gianotti R, Coggi A, Boggio F, Fellegara G.
Acta Derm Venereol. 2020 Aug 12. doi: 10.2340/00015555-3612. Online ahead of print. Case series / pathology study.
https://doi.org/10.2340/00015555-3612

Acro-ischemic lesions associated with extremely elevated D-Dimer in a child during the COVID-19 pandemic.
García-Gil MF, Monte Serrano J, García García M, Pascual-Del-Riquelme JA, Ara-Martín M.
Australas J Dermatol. 2020 Aug 17. doi: 10.1111/ajd.13424. Online ahead of print. Case report.
https://doi.org/10.1111/ajd.13424

Chilblains and COVID-19: why SARS-CoV-2 endothelial infection is questioned.
Baeck M, Hoton D, Marot L, Herman A.
Br J Dermatol. 2020 Aug 15. doi: 10.1111/bjd.19489. Online ahead of print. Commentary.
https://doi.org/10.1111/bjd.19489

Chilblains and COVID-19: why SARS-CoV-2 endothelial infection is questioned: reply from authors.
Colmenero I, Santonja C, Alonso-Riaño M, Andina D, Rodríguez-Peralto JL, Requena L, Torrelo A.
Br J Dermatol. 2020 Aug 15. doi: 10.1111/bjd.19491. Online ahead of print. Commentary.
https://doi.org/10.1111/bjd.19491

Negative tests for SARS-CoV-2 infection do not rule out its responsibility for chilblains.
Battesti G, Descamps Vincent V.
Br J Dermatol. 2020 Aug 13. doi: 10.1111/bjd.19483. Online ahead of print. Commentary.
https://doi.org/10.1111/bjd.19483

Negative tests for SARS-CoV-2 infection do not rule out its responsibility for chilblains: reply from authors.
Le Cleach L, Fourati S, Sbidian E, Beylot-Barry M.
Br J Dermatol. 2020 Aug 13. doi: 10.1111/bjd.19486. Online ahead of print. Commentary.
https://doi.org/10.1111/bjd.19486

The differing pathophysiologies that underlie COVID-19 associated perniosis and thrombotic retiform purpura: a case series.
Magro C, Mulvey JJ, Laurence J, Sanders S, Crowson N, Grossman M, Harp J, Nuovo G.
Br J Dermatol. 2020 Jul 22:10.1111/bjd.19415. doi: 10.1111/bjd.19415. Online ahead of print. Case series / pathology study.
https://doi.org/10.1111/bjd.19415

All that glisters is not COVID: low prevalence of seroconversion against SARS-CoV-2 in a pediatric cohort of patients with chilblain-like lesions.
Denina M, Pellegrino F, Morotti F, Coppo P, Bonsignori IM, Garazzino S, Ravanini P, Avolio M, Cavallo R, Bertolotti L, Felici E, Acucella G, Montin D, Rabbone I, Licciardi F.
J Am Acad Dermatol. 2020 Aug 8:S0190-9622(20)32409-9. doi: 10.1016/j.jaad.2020.08.021. Online ahead of print. Case series / pathology study.
https://doi.org/10.1016/j.jaad.2020.08.021

Perniosis during the COVID-19 pandemic: Negative anti-SARS-CoV-2 immunohistochemistry in six patients and comparison to perniosis before the emergence of SARS-CoV-2.
Ko CJ, Harigopal M, Damsky W, Gehlhausen JR, Bosenberg M, Patrignelli R, McNiff JM.
J Cutan Pathol. 2020 Aug 3. doi: 10.1111/cup.13830. Online ahead of print. Case series & pathology study.
https://doi.org/10.1111/cup.13830

Approach to chilblains during the COVID-19 pandemic.
Ladha MA, Luca N, Constantinescu C, Naert K, Ramien ML.
J Cutan Med Surg. 2020 Aug 3:1203475420937978. doi: 10.1177/1203475420937978. Online ahead of print. Review.
https://doi.org/10.1177/1203475420937978

Going viral: A brief history of chilblain-like skin lesions ("COVID toes") amidst the COVID-19 pandemic.
Massey PR, Jones KM.
Semin Oncol. 2020 May 23:S0093-7754(20)30051-8. doi: 10.1053/j.seminoncol.2020.05.012. Online ahead of print. Review.
https://doi.org/10.1053/j.seminoncol.2020.05.012

Auricle perniosis as a manifestation of Covid-19 infection.
Proietti I, Tolino E, Bernardini N, Mambrin A, Balduzzi V, Marchesiello A, Michelini S, Del Borgo C, Skroza, Lichtner M, Potenza C.
Dermatol Ther. 2020 Jul 27:e14089. doi: 10.1111/dth.14089. Online ahead of print. Case report.
https://doi.org/10.1111/dth.14089

Chilblain rash during the COVID-19 pandemic in a 13-year-old girl: Case report and review of literature on cutaneous manifestations during the COVID-19 pandemic.
Mann N, Dobson J, Llewellyn J.
Dermatological Nursing 2020. 19(2):30-34.

Oral vesicles and acral erythema: report of a cutaneous manifestation of COVID-19.
Aghazadeh N, Homayouni M, Sartori-Valinotti JC.
Int J Dermatol. 2020 Jul 25. doi: 10.1111/ijd.15047. Online ahead of print. Case report.
https://doi.org/10.1111/ijd.15047

Lack of association between chilblains outbreak and SARS-CoV-2: histological and serological findings from a new immunoassay.
Hébert V, Duval-Modeste AB, Joly P, Lemée V, Cellier L, Jouen F, Veber B, Drouot L, Boyer O.
J Am Acad Dermatol. 2020 Jul 16. pii: S0190-9622(20)32217-9. doi: 10.1016/j.jaad.2020.07.048. [Epub ahead of print] No abstract available. Case series / pathology study.
https://doi.org/10.1016/j.jaad.2020.07.048

Covid toes: Phenomenon or epiphenomenon?
Deutsch A, Blasiak R, Keyes A, Wu J, Marmon S, Asrani F, Moy J, Russo M, McLellan BN.
J Am Acad Dermatol. 2020 Jul 16. pii: S0190-9622(20)32206-4. doi: 10.1016/j.jaad.2020.07.037. [Epub ahead of print] No abstract available. Commentary.
https://doi.org/10.1016/j.jaad.2020.07.037

SARS-CoV-2-related chilblains.
Ladha MA, Dupuis EC.
CMAJ. 2020 Jul 13;192(28):E804. doi: 10.1503/cmaj.201348. No abstract available. Case report.
https://doi.org/10.1503/cmaj.201348

Are chilblains a skin expression of COVID-19 microangiopathy?
Baeck M, Herman A, Peeters C, Marot L, Hermans C.
J Thromb Haemost. 2020 Jul 13. doi: 10.1111/jth.15008. [Epub ahead of print]. Commentary.
https://doi.org/10.1111/jth.15008

Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on PCR and serology testing.
Le Cleach L, Dousset L, Assier H, Fourati S, Barbarot S, Boulard C, Bourseau Quetier C, Cambon L, Cazanave C, Colin A, Kostrzewa E, Lesort C, Levy Roy A, Lombart F, Marco-Bonnet J, Monfort JB, Samimi M, Tardieu M, Wolkenstein P, Sbidian E, Beylot-Barry M; French Society of Dermatology.
Br J Dermatol. 2020 Jul 6. doi: 10.1111/bjd.19377. [Epub ahead of print]. Survey & pathology study.
https://doi.org/10.1111/bjd.19377

New insights in COVID-19-associated chilblains: a comparative study with chilblain lupus erythematosus.
Battesti G, El Khalifa J, Abdelhedi N, Ferre V, Bouscarat F, Picard-Dahan C, Brunet-Possenti F, Collin G, Lavaud J, Le Bozec P, Rousselot M, Tournier A, Lheure C, Couvelard A, Hacein-Bey-Abina S, Abina AM, Charpentier C, Mignot S, Nicaise P, Descamps D, Deschamps L, Descamps V.
J Am Acad Dermatol. 2020 Jul 2. pii: S0190-9622(20)32147-2. doi: 10.1016/j.jaad.2020.06.1018. [Epub ahead of print] No abstract available. Case series.
https://doi.org/10.1016/j.jaad.2020.06.1018

Dermoscopy features of COVID-19-related chilblains in children and adolescents.
Navarro L, Andina D, Noguera-Morel L, Hernández-Martín A, Colmenero I, Torrelo A.
J Eur Acad Dermatol Venereol. 2020 Jul 2. doi: 10.1111/jdv.16800. [Epub ahead of print]. Case series.
https://doi.org/10.1111/jdv.16800

Coronavirus (COVID-19) infection-induced chilblains: A brisk perieccrine inflammatory response.
Wargo JJ, Weir NM, Shamma HN.
Am J Dermatopathol. 2020 Jun 30. doi: 10.1097/DAD.0000000000001733. [Epub ahead of print]. Case report.
https://doi.org/10.1097/DAD.0000000000001733

Concurrent chilblains and retinal vasculitis in a child with COVID-19.
Quintana-Castanedo L, Feito-Rodríguez M, Fernández-Alcalde C, Granados-Fernández M, Montero-Vega D, Mayor-Ibarguren A, de Lucas-Laguna R.
J Eur Acad Dermatol Venereol. 2020 Jul 2. doi: 10.1111/jdv.16801. [Epub ahead of print]. Case report.
https://doi.org/10.1111/jdv.16801

Chilblain-like lesions during COVID-19 pandemic: a serological study on a case series.
Rizzoli L, Collini L, Magnano M, Termine S, Barcelli R, Infusino SD, Bauer P, Rech G, Girardelli CR, Balestri R.
Br J Dermatol. 2020 Jul 1. doi: 10.1111/bjd.19348. [Epub ahead of print]. Case series / pathology study.
https://doi.org/10.1111/bjd.19348

No evidence of SARS-Cov-2 infection by PCR or serology in children with pseudochilblain.
Caselli D, Chironna M, Loconsole D, Nigri L, Mazzotta F, Bonamonte D, Aricò M.
Br J Dermatol. 2020 Jul 1. doi: 10.1111/bjd.19349. [Epub ahead of print]. Case series / pathology study.
https://doi.org/10.1111/bjd.19349

Acral edema during the COVID-19 pandemic.
Valtueña J, Ruiz-Sánchez D, Volo V, Manchado-López P, Garayar-Cantero M.
Int J Dermatol. 2020 Jul 1. doi: 10.1111/ijd.15025. [Epub ahead of print] No abstract available. Case reports.
https://doi.org/10.1111/ijd.15025

COVID-19 lockdown induced acral dermatosis in children.
Bodak N, Chiaverini C, Barbarot S.
J Eur Acad Dermatol Venereol. 2020 Jun 28. doi: 10.1111/jdv.16797. [Epub ahead of print]. Case series.
https://doi.org/10.1111/jdv.16797

COVID-19 and outbreak of chilblains: are they related?
Lesort C, Kanitakis J, Villani A, Ducroux E, Bouschon P, Fattouh K, Bensaid B, Danset M, Jullien D.
J Eur Acad Dermatol Venereol. 2020 Jun 27. doi: 10.1111/jdv.16779. [Epub ahead of print]. Case series.
https://doi.org/10.1111/jdv.16779

Erythematous-oedematous type of chilblain-like lesions and COVID-19 : an Indian perspective.
Das A, Singh V.
Dermatol Ther. 2020 Jun 27:e13912. doi: 10.1111/dth.13912. [Epub ahead of print] No abstract available. Case series.
https://doi.org/10.1111/dth.13912

[Chilblains in lockdown: an old acquaintance in the context of COVID-19].
Català Gonzalo A, Galván Casas C.
An Pediatr (Barc). 2020 Jun 11. pii: S1695-4033(20)30190-9. doi: 10.1016/j.anpedi.2020.06.002. [Epub ahead of print] Spanish. No abstract available. Commentary.
https://doi.org/10.1016/j.anpedi.2020.06.002

Acute acral cutaneous manifestations during the COVID-19 pandemic: a single center experience.
García-Legaz Martínez M, Martínez-Doménech Á, Magdaleno-Tapial J, Valenzuela-Oñate C, Partarrieu-Mejías F, Lorca-Spröhnle J, Casanova-Esquembre A, Pérez-Ferriols A, Alegre-de Miquel V.
J Eur Acad Dermatol Venereol. 2020 Jun 26. doi: 10.1111/jdv.16777. [Epub ahead of print]. Case series.
https://doi.org/10.1111/jdv.16777

Recent outbreak of chilblain-like lesions is not directly related with SARS-CoV-2 infection.
Rouanet J, Lang E, Beltzung F, Evrard B, Henquell C, Joulie I, D'Incan M.
J Eur Acad Dermatol Venereol. 2020 Jun 26. doi: 10.1111/jdv.16776. [Epub ahead of print]. Case series.
https://doi.org/10.1111/jdv.16776

Focus on "COVID Toes".
Hernandez C, Bruckner AL.
JAMA Dermatol. 2020 Jun 25. doi: 10.1001/jamadermatol.2020.2062. [Epub ahead of print] No abstract available. Editorial.
https://doi.org/10.1001/jamadermatol.2020.2062

Evaluation of chilblains as a manifestation of the COVID-19 pandemic.
Herman A, Peeters C, Verroken A, Tromme I, Tennstedt D, Marot L, Dachelet C, Gruson D, Hermans C, Baeck M.
JAMA Dermatol. 2020 Jun 25. doi: 10.1001/jamadermatol.2020.2368. [Epub ahead of print]. Case series & pathology study.
https://doi.org/10.1001/jamadermatol.2020.2368

Assessment of acute acral lesions in a case series of children and adolescents during the COVID-19 pandemic.
Roca-Ginés J, Torres-Navarro I, Sánchez-Arráez J, Abril-Pérez C, Sabalza-Baztán O, Pardo-Granell S, Martínez I Cózar V, Botella-Estrada R, Évole-Buselli M.
JAMA Dermatol. 2020 Jun 25. doi: 10.1001/jamadermatol.2020.2340. [Epub ahead of print]. Case series & pathology study.
https://doi.org/10.1001/jamadermatol.2020.2340

COVID-19 chilblain-like lesion: immunohistochemical demonstration of SARS-CoV-2 spike protein in blood vessel endothelium and sweat gland epithelium in a PCR-negative patient.
Santonja C, Heras F, Núñez L, Requena L.
Br J Dermatol. 2020 Jun 25. doi: 10.1111/bjd.19338. [Epub ahead of print]. Case report.
https://doi.org/10.1111/bjd.19338

The mystery of the COVID toes - turning evidence-based medicine on its head.
Bristow IR, Borthwick AM.
J Foot Ankle Res. 2020 Jun 23;13(1):38. doi: 10.1186/s13047-020-00408-w. Review / commentary.
https://doi.org/10.1186/s13047-020-00408-w

Understanding the role that 'COVID toe' has in recognizing the potential extent of COVID-19 infections: a case study.
Noakes A, Majoe S.
Pathog Glob Health. 2020 Jun 24:1-2. doi: 10.1080/20477724.2020.1785200. [Epub ahead of print]. Case reports.
https://doi.org/10.1080/20477724.2020.1785200

Chilblains and COVID19 infection: Causality or coincidence? How to proceed?
Pistorius MA, Blaise S, Le Hello C; French Society for Microcirculation, Barbarot S, Dréno B.
J Med Vasc. 2020 Jul;45(4):221-223. doi: 10.1016/j.jdmv.2020.05.002. Epub 2020 May 11. No abstract available. Review / commentary.
https://doi.org/10.1016/j.jdmv.2020.05.002

Chilblain-like lesions during the COVID-19 pandemic: early or late sign?
Recalcati S, Fantini F.
Int J Dermatol. 2020 Jun 22. doi: 10.1111/ijd.14975. [Epub ahead of print] No abstract available. Commentary.
https://doi.org/10.1111/ijd.14975

When interferon tiptoes through COVID-19: Pernio-like lesions and their prognostic implications during SARS-CoV-2 infection.
Damsky W, Peterson D, King B.J Am Acad Dermatol. 2020 Jun 18. pii: S0190-9622(20)31150-6. doi: 10.1016/j.jaad.2020.06.052. [Epub ahead of print] No abstract available. Review / commentary.
https://doi.org/10.1016/j.jaad.2020.06.052

Chilblain and acral purpuric lesions in COVID-19.
Wiwanitkit V.
Actas Dermosifiliogr. 2020 Jun 18. pii: S0001-7310(20)30194-0. doi: 10.1016/j.ad.2020.06.002. [Epub ahead of print] English, Spanish. No abstract available. Letter / commentary.
https://doi.org/10.1016/j.ad.2020.06.002

Negative SARS-CoV-2 PCR in patients with chilblain-like lesions.
Hubiche T, Le Duff F, Chiaverini C, Giordanengo V, Passeron T.
Lancet Infect Dis. 2020 Jun 18. pii: S1473-3099(20)30518-1. doi: 10.1016/S1473-3099(20)30518-1. [Epub ahead of print] No abstract available. Prospective cohort study.
https://doi.org/10.1016/S1473-3099(20)30518-1

SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultraestructural study of 7 paediatric cases.
Colmenero I, Santonja C, Alonso-Riaño M, Noguera-Morel L, Hernández-Martín A, Andina D, Wiesner T, Rodríguez-Peralto JL, Requena L, Torrelo A.
Br J Dermatol. 2020 Jun 20. doi: 10.1111/bjd.19327. [Epub ahead of print]. Case series / pathological study.
https://doi.org/10.1111/bjd.19327

Major cluster of pediatric " true " primary chilblains during the COVID-19 pandemic: a consequence of lifestyle changes due to lockdown.
Iria N, Annalucia V, Ilaria C, Alba G, Tiziana L, Liliana G, Cosimo M, Annalisa P, Marcello L.
J Eur Acad Dermatol Venereol. 2020 Jun 13. doi: 10.1111/jdv.16751. [Epub ahead of print]. Case series.
https://doi.org/10.1111/jdv.16751

Outbreak of chilblain-like acral lesions in children in the metropolitan area of Milan, Italy, during the COVID-19 pandemic.
Colonna C, Genovese G, Monzani NA, Picca M, Boggio F, Gianotti R, Marzano AV.
J A Acad Dermatol. 2020 Jun 10. pii: S0190-9622(20)31079-3. doi: 10.1016/j.jaad.2020.06.019. [Epub ahead of print] No abstract available. Case series.
https://doi.org/10.1016/j.jaad.2020.06.019

Chilblains in children in the time of Covid-19: new evidence with serology assay.
Colonna C, Spinelli F, Monzani NA, Ceriotti F, Gelmetti C.
Pediatr Dermatol. 2020 Jun 13. doi: 10.1111/pde.14269. [Epub ahead of print]. Commentary.
https://doi.org/10.1111/pde.14269

A chilblain epidemic during the COVID-19 pandemic. A sign of natural resistance to SARS-CoV-2?
Lipsker D.
Med Hypotheses. 2020 Jun 6;144:109959. doi: 10.1016/j.mehy.2020.109959. [Epub ahead of print] No abstract available. Commentary.
https://doi.org/10.1016/j.mehy.2020.109959

Histological findings in chilblain-lupus like COVID lesions: in search of an answer to understand their etiology.
Rodríguez-Villa Lario A, Vega-Díez D, González-Cañete M, Gómez-Zubiaur A, Pérez-Mesonero R, Bandini M, Polo-Rodríguez I, Vélez-Velázquez D, Trasobares-Marugán L.
J Eur Acad Dermatol Venereol. 2020 Jun 12. doi: 10.1111/jdv.16733. [Epub ahead of print]. Commentary.
https://doi.org/10.1111/jdv.16733

Chilblain-like acral lesions during the COVID-19 pandemic ("covid toes"): Histologic, immunofluorescence and immunohistochemical study of 17 cases.
Kanitakis J, Lesort C, Danset M, Jullien D.
J Am Acad Dermatol. 2020 Jun 2. pii: S0190-9622(20)31022-7. doi: 10.1016/j.jaad.2020.05.145. [Epub ahead of print]. Pathology study / case series.
https://doi.org/10.1016/j.jaad.2020.05.145

Chilblain-like lesions during the COVID-19 pandemic: should we really worry?
Piccolo V, Neri I, Manunza F, Mazzatenta C, Bassi A.
Int J Dermatol. 2020 Jun 4. doi: 10.1111/ijd.14993. [Epub ahead of print] No abstract available. Commentary.
https://doi.org/10.1111/ijd.14993

Chilblains-like dermatologic manifestation of COVID-19 diagnosed by serology via multidisciplinary virtual care.
Kerber AA, Soma DB, Youssef MJ.
Int J Dermatol. 2020 Jun 4. doi: 10.1111/ijd.14974. [Epub ahead of print] No abstract available. Case report.
https://doi.org/10.1111/ijd.14974

Reply to: "Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak".
Ruggiero G, Arcangeli F, Lotti T, Ametrano O, Ruggiero C, Cucchiara S, Oliva S.
J Am Acad Dermatol. 2020 Jun 1. pii: S0190-9622(20)30998-1. doi: 10.1016/j.jaad.2020.05.122. [Epub ahead of print] No abstract available. Commentary.
https://doi.org/10.1016/j.jaad.2020.05.122

Comment on: "Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak".
Fernandez-Nieto D, Jimenez-Cauhe J, Suarez-Valle A, Moreno-Arrones OM, Saceda-Corralo D, Arana-Raja A, Ortega-Quijano D.
J Am Acad Dermatol. 2020 Jun 1. pii: S0190-9622(20)30996-8. doi: 10.1016/j.jaad.2020.05.120. [Epub ahead of print] No abstract available. Comment.
https://doi.org/10.1016/j.jaad.2020.05.120

No antibody response in acral cutaneous manifestations associated with COVID-19?
Mahieu R, Tillard L, Le Guillou-Guillemette H, Vinatier E, Jeannin P, Croué A, Le Corre Y, Vandamme YM.
J Eur Acad Dermatol Venereol. 2020 Jun 2. doi: 10.1111/jdv.16688. [Epub ahead of print]. Pathology study / case series.
https://doi.org/10.1111/jdv.16688

Acro-ischemia and COVID-19 infection: clinical and histopathological features.
Calvão J, Relvas M, Pinho A, Brinca A, Cardoso JC.
J Eur Acad Dermatol Venereol. 2020 Jun 2. doi: 10.1111/jdv.16687. [Epub ahead of print]. Case report.
https://doi.org/10.1111/jdv.16687

Pernio-like skin lesions associated with COVID-19: a case series of 318 patients from 8 countries.
Freeman EE, McMahon DE, Lipoff JB, Rosenbach M, Kovarik C, Takeshita J, French LE, Thiers BH, Hruza GJ, Fox LP; American Academy of Dermatology Ad Hoc Task Force on Covid-19.
J Am Acad Dermatol. 2020 May 29. pii: S0190-9622(20)30984-1. doi: 10.1016/j.jaad.2020.05.109. [Epub ahead of print]. Registry-based case series.
https://doi.org/10.1016/j.jaad.2020.05.109

A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection.
El Hachem M, Diociaiuti A, Concato C, Carsetti R, Carnevale C, Ciofi Degli Atti M, Giovannelli L, Latella E, Porzio O, Rossi S, Stracuzzi A, Zaffina S, Onetti Muda A, Zambruno G, Alaggio R.
J Eur Acad Dermatol Venereol. 2020 May 31. doi: 10.1111/jdv.16682. [Epub ahead of print]. Prospective cohort study.
https://doi.org/10.1111/jdv.16682

Further evidence that chilblains are a cutaneous manifestation of COVID-19 infection.
Hughes M, Rogers S, Lepri G, Bruni C, Matucci-Cerinic M.
Br J Dermatol. 2020 May 27. doi: 10.1111/bjd.19243. [Epub ahead of print]. Analysis of Internet searh data.
https://doi.org/10.1111/bjd.19243

[Acro-ischemic skin lesions during COVID-19 epidemic].
Monte Serrano J, Cruañes Monferrer J, García-Gil MF.
Semergen. 2020 May 8. pii: S1138-3593(20)30142-8. doi: 10.1016/j.semerg.2020.05.003. [Epub ahead of print] Spanish. No abstract available. Case report.
https://doi.org/10.1016/j.semerg.2020.05.003

Are chilblain-like acral skin lesions really indicative of COVID-19? A prospective study and literature review.
Docampo-Simón A, Sánchez-Pujol MJ, Juan-Carpena G, Palazón-Cabanes JC, Vergara-De Caso E, Berbegal L, Poveda-Montoyo I, Pastor-Tomás N, Mataix-Díaz J, Terencio-Alemany C, Martínez-Torres A, Miralles-Botella J, Blanes-Martínez M, González-Villanueva I, Betlloch-Mas I.
J Eur Acad Dermatol Venereol. 2020 May 26. doi: 10.1111/jdv.16665. [Epub ahead of print]. Case series / cohort study.
https://doi.org/10.1111/jdv.16665

Chilblains-like lesions and COVID-19.
Joob B, Wiwanitkit V.
Pediatr Dermatol. 2020 May 26. doi: 10.1111/pde.14238. [Epub ahead of print]. Commentary.
https://doi.org/10.1111/pde.14238

Acral findings during the COVID-19 outbreak: Chilblain-like lesions should be preferred to acro-ischemic lesions.
Piccolo V, Bassi A.
J Am Acad Dermatol. 2020 May 21. pii: S0190-9622(20)30946-4. doi: 10.1016/j.jaad.2020.05.077. [Epub ahead of print] No abstract available. Case reports.
https://doi.org/10.1016/j.jaad.2020.05.077

Comment on: "Acral findings during the COVID-19 outbreak: Chilblain-like lesions should be preferred to acro-ischemic lesions".
Fernandez-Nieto D, Jimenez-Cauhe J, Suarez-Valle A, MorenoArrones OM, Saceda-Corralo D, Arana-Raja A, OrtegaQuijano D.
J Am Acad Dermatol. 2020 May 21. pii: S0190-9622(20)30947-6. doi: 10.1016/j.jaad.2020.05.078. [Epub ahead of print] No abstract available. Commentary.
https://doi.org/10.1016/j.jaad.2020.05.078

Images in practice: Painful cutaneous vasculitis in a SARS-Cov-2 IgG-positive child.
Papa A, Salzano AM, Di Dato MT, Varrassi G.
Pain Ther. 2020 May 21. doi: 10.1007/s40122-020-00174-4. [Epub ahead of print] No abstract available. Case report.
https://doi.org/10.1007/s40122-020-00174-4

Silent COVID-19: what your skin can reveal.
Guarneri C, Rullo EV, Pavone P, Berretta M, Ceccarelli M, Natale A, Nunnari G.
Lancet Infect Dis. 2020 May 18. pii: S1473-3099(20)30402-3. doi: 10.1016/S1473-3099(20)30402-3. [Epub ahead of print] No abstract available. Case reports.
https://doi.org/10.1016/S1473-3099(20)30402-3

Visual dermatology: Acral erythemato-purpuric lesions during COVID-19 pandemic.
Ferrara G, Morgado-Carrasco D.
J Cutan Med Surg. 2020 May 21:1203475420929919. doi: 10.1177/1203475420929919. [Epub ahead of print] No abstract available. Case photographs.
https://doi.org/10.1177/1203475420929919

Viral exanthem with "pin and needles sensation" on extremities of COVID-19 patient.
Putra BE, Adiarto S, Dewayanti SR, Juzar DA.
Int J Infect Dis. 2020 May 8. pii: S1201-9712(20)30327-1. doi: 10.1016/j.ijid.2020.05.020. [Epub ahead of print]. Case report.
https://doi.org/10.1016/j.ijid.2020.05.020

The management of the outbreak of acral skin manifestations in asymptomatic children during COVID-19 era.
Mastrolonardo M, Romita P, Bonifazi E, Giuffrida R, Lotti T, Foti C, Bonamonte D.
Dermatol Ther. 2020 May 18:e13617. doi: 10.1111/dth.13617. [Epub ahead of print] No abstract available. Case series & commentary.
https://doi.org/10.1111/dth.13617

Therapy for probable COVID-19 associated erythema pernio-like lesions in pediatric age. Case report.
Ruggiero G, Arcangeli F, Lotti T.
Dermatol Ther. 2020 May 18:e13616. doi: 10.1111/dth.13616. [Epub ahead of print] No abstract available. Case report.
https://doi.org/10.1111/dth.13616

Novel outbreak of acral lesions in times of COVID-19: A description of 74 cases from a tertiary university hospital in Spain.
Saenz Aguirre A, De la Torre Gomar FJ, Rosés-Gibert P, Gimeno Castillo J, Martinez de Lagrán Alvarez de Arcaya Z, Gonzalez-Perez R.
Clin Exp Dermatol. 2020 May 18. doi: 10.1111/ced.14294. [Epub ahead of print]. Case series.
https://doi.org/10.1111/ced.14294

Chilblain acral lesions in the COVID-19 era. Are they marker of infection in asymptomatic patients?
Ramondetta A, Panzone M, Dapavo P, Ortoncelli M, Giura MT, Licciardello M, Rozzo G, Siliquini N, Fierro MT, Ribero S.
J Eur Acad Dermatol Venereol. 2020 May 18. doi: 10.1111/jdv.16636. [Epub ahead of print]. Clinical report / commentary.
https://doi.org/10.1111/jdv.16636

[Perniosis-like skin lesions during the COVID-19 epidemic].
Monte Serrano J, Cruañes Monferrer J, Matovelle Ochoa C, García-Gil MF.
An Pediatr (Barc). 2020 Apr 30. pii: S1695-4033(20)30174-0. doi: 10.1016/j.anpedi.2020.04.018. [Epub ahead of print] Spanish. No abstract available. Case reports.
https://doi.org/10.1016/j.anpedi.2020.04.018

Skin involvement in SARS-CoV-2 infection: Case series.
Diotallevi F, Campanati A, Bianchelli T, Bobyr I, Luchetti MM, Marconi B, Martina E, Radi G, Offidani A.
J Med Virol. 2020 May 15. doi: 10.1002/jmv.26012. [Epub ahead of print]. Case series.
https://doi.org/10.1002/jmv.26012

Clustered cases of acral perniosis: Clinical features, histopathology and relationship to COVID-19.
Cordoro KM, Reynolds SD, Wattier R, McCalmont TH.
Pediatr Dermatol. 2020 May 12. doi: 10.1111/pde.14227. [Epub ahead of print]. Case reports.
https://doi.org/10.1111/pde.14227

Chilblains in children in the setting of COVID-19 pandemic.
Andina D, Noguera-Morel L, Bascuas-Arribas M, Gaitero-Tristán J, Alonso-Cadenas JA, Escalada-Pellitero S, Hernández-Martín Á, de la Torre-Espi M, Colmenero I, Torrelo A.
Pediatr Dermatol. 2020 May 9. doi: 10.1111/pde.14215. [Epub ahead of print]. Retrospective case review.
https://doi.org/10.1111/pde.14215

Histologic features of long lasting chilblain-like lesions in a pediatric COVID-19 patient.
Locatelli AG, Robustelli Test E, Vezzoli P, Carugno A, Moggio E, Consonni L, Gianatti A, Sena P.
J Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16617. [Epub ahead of print]. Case report.
https://doi.org/10.1111/jdv.16617

Re: Chilblain-like lesions on feet and hands during the COVID-19 pandemic.
El-Azhary R.
Int J Dermatol. 2020 May 8. doi: 10.1111/ijd.14956. [Epub ahead of print] No abstract available. Letter.
https://doi.org/10.1111/ijd.14956

Acro-ischemia in hospitalized COVID-19 patients.
Suarez-Valle A, Fernandez-Nieto D, Diaz-Guimaraens B, Dominguez-Santas M, Carretero I, Perez-Garcia B.
J Eur Acad Dermatol Venereol. 2020 May 7. doi: 10.1111/jdv.16592. [Epub ahead of print]. Case reports.
https://doi.org/10.1111/jdv.16592

Chilblain-like lesions in pediatrics dermatological outpatients during the COVID-19 outbreak.
Garcia-Lara G, Linares-González L, Ródenas-Herranz T, Ruiz-Villaverde R.
Dermatol Ther. 2020 May 6:e13516. doi: 10.1111/dth.13516. [Epub ahead of print] Review. No abstract available. Retrospective cross-sectional study.
https://doi.org/10.1111/dth.13516 

Chilblains-like lesions in children following suspected Covid-19 infection.
Colonna C, Monzani NA, Rocchi A, Gianotti R, Boggio F, Gelmetti C.
Pediatr Dermatol. 2020 May 6. doi: 10.1111/pde.14210. [Epub ahead of print]. Case reports.
https://doi.org/10.1111/pde.14210

Chilblain-like lesions: a case series of 41 patients during the COVID-19 pandemic.
López-Robles J, de la Hera I, Pardo J, Martínez J, Cutillas-Marco E.
Clin Exp Dermatol. 2020 May 5. doi: 10.1111/ced.14275. [Epub ahead of print]. Case series.
https://doi.org/10.1111/ced.14275

Chilblains are a common cutaneous finding during the COVID-19 pandemic: a retrospective nationwide study from France.
de Masson A, Bouaziz JD, Sulimovic L, Cassius C, Jachiet M, Ionescu MA, Rybojad M, Bagot M, Duong TA; SNDV (French Union of Dermatologists-Venereologists).
J Am Acad Dermatol. 2020 May 4. pii: S0190-9622(20)30789-1. doi: 10.1016/j.jaad.2020.04.161. [Epub ahead of print] No abstract available. Retrospective observational study.
https://doi.org/10.1016/j.jaad.2020.04.161

Skin signs resembling vascular acrosyndromes during the COVID-19 outbreak in Italy.
Tosti G, Barisani A, Queirolo P, Pennacchioli E, Villa L, Lodeserto AM, Vaccari S.
Clin Exp Dermatol. 2020 May 2. doi: 10.1111/ced.14267. [Epub ahead of print]. Case reports.
https://doi.org/10.1111/ced.14267

The use of Google trends for acral symptoms during COVID-19 outbreak in France.
Kluger N, Scrivener Y.
J Eur Acad Dermatol Venereol. 2020 May 2. doi: 10.1111/jdv.16572. [Epub ahead of print]. Survey / research study.
https://doi.org/10.1111/jdv.16572

Comment on 'Two cases of COVID-19 presenting with a clinical picture resembling chilblains: first report from the Middle East': pernio unrelated to COVID-19.
Torres-Navarro I, Abril-Pérez C, Roca-Ginés J, Sánchez-Arráez J, Botella-Estrada R, Évole-Buselli M.
Clin Exp Dermatol. 2020 May 1. doi: 10.1111/ced.14255. [Epub ahead of print]. Letter.
https://doi.org/10.1111/ced.14255

[Chilblains in lockdown: An old acquaintance in the context of COVID-19.]
Abril-Pérez C, Sánchez-Arráez J, Roca-Ginés J, Torres-Navarro I.
An Pediatr (Barc). 2020 Apr 25. pii: S1695-4033(20)30173-9. doi: 10.1016/j.anpedi.2020.04.017. [Epub ahead of print] Spanish. No abstract available. Case report.
https://doi.org/10.1016/j.anpedi.2020.04.017

Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak.
Fernandez-Nieto D, Jimenez-Cauhe J, Suarez-Valle A, Moreno-Arrones OM, Saceda-Corralo D, Arana-Raja A, Ortega-Quijano D.
J Am Acad Dermatol. 2020 Apr 24. pii: S0190-9622(20)30709-X. doi: 10.1016/j.jaad.2020.04.093. [Epub ahead of print] No abstract available. Case series.
https://doi.org/10.1016/j.jaad.2020.04.093

Chilblain-like lesions on feet and hands during the COVID-19 pandemic.
Landa N, Mendieta-Eckert M, Fonda-Pascual P, Aguirre T.
Int J Dermatol. 2020 Apr 24. doi: 10.1111/ijd.14937. [Epub ahead of print] No abstract available. Case series & commentary.
https://doi.org/10.1111/ijd.14937

Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients.
Piccolo V, Neri I, Filippeschi C, Oranges T, Argenziano G, Battarra VC, Berti S, Manunza F, Belloni Fortina A, Di Lernia V, Boccaletti V, De Bernardis G, Brunetti B, Mazzatenta C, Bassi A.
J Eur Acad Dermatol Venereol. 2020 Apr 24. doi: 10.1111/jdv.16526. [Epub ahead of print]. Case series.
https://doi.org/10.1111/jdv.16526

Acral cutaneous lesions in the time of COVID-19.
Recalcati S, Barbagallo T, Frasin LA, Prestinari F, Cogliardi A, Provero MC, Dainese E, Vanzati A, Fantini F.
J Eur Acad Dermatol Venereol. 2020 Apr 24. doi: 10.1111/jdv.16533. [Epub ahead of print]. Case series.
https://doi.org/10.1111/jdv.16533

Chilblain and acral purpuric lesions in Spain during covid confinement: Retrospective analysis of 12 cases.
Romaní J, Baselga E, Mitjà O, Riera-Martí N, Garbayo P, Vicente A, Casals M, Fumadó V, Fortuny C, Calzado S.
Actas Dermosifiliogr. 2020 Apr 22. pii: S0001-7310(20)30087-9. doi: 10.1016/j.ad.2020.04.002. [Epub ahead of print] Spanish, English. No abstract available. Case series.
https://doi.org/10.1016/j.ad.2020.04.002

Addressing the question of dermatologic manifestations of SARS-CoV-2 infection in the lower extremities: A closer look at the available data and its implications.
Basatneh R, Vlahovic TC.
J Am Podiatr Med Assoc. 2020 Apr 20. doi: 10.7547/20-074. [Epub ahead of print] No abstract available. Review.
https://doi.org/10.7547/20-074

Coronavirus (COVID-19) infection-induced chilblains: A case report with histopathologic findings.
Kolivras A, Dehavay F, Delplace D, Feoli F, Meiers I, Milone L, Olemans C, Sass U, Theunis A, Thompson CT, Van De Borne L, Richert B.
JAAD Case Rep. 2020 Apr 18. doi: 10.1016/j.jdcr.2020.04.011. [Epub ahead of print] No abstract available. Case report.
https://doi.org/10.1016/j.jdcr.2020.04.011

A new vasculitis at the time of COVID-19.
Mazzotta F., Troccoli T., Bonifazi E.
European Journal Of Pediatric Dermatology - pd online, Monday's case. Case report.
Accessed 17/04/20.
https://www.ejpd.com/images/nuova-vasculite-covid-ENG.pdf

Eruption as a clinical manifestation of COVID-19: photographs of a patient.
Hoenig LJ, Pereira FA.
Clin Dermatol. 2020 Jul-Aug;38(4):502-505. doi: 10.1016/j.clindermatol.2020.04.001. Epub 2020 Apr 7. Case report.
https://doi.org/10.1016/j.clindermatol.2020.04.001

A case of COVID-19 presenting in clinical picture resembling chilblains disease. First report from the Middle East.
Alramthan A, Aldaraji W.
Clin Exp Dermatol. 2020 Apr 17. doi: 10.1111/ced.14243. [Epub ahead of print]. Case report.
https://doi.org/10.1111/ced.14243

Cutaneous manifestations in COVID-19: a new contribution.
Estébanez A, Pérez-Santiago L, Silva E, Guillen-Climent S, García-Vázquez A, Ramón MD.
J Eur Acad Dermatol Venereol. 2020 Apr 15. doi: 10.1111/jdv.16474. [Epub ahead of print]. Case report.
https://doi.org/10.1111/jdv.16474

 

Back to CEBD Coronavirus Dermatology Resource Homepage

Centre of Evidence Based Dermatology

The University of Nottingham
King's Meadow Campus
Lenton Lane
Nottingham, NG7 2NR


telephone: +44 (0) 115 823 1048
email:cebd@nottingham.ac.uk